Introduction
Stress echocardiography and myocardial perfusion imaging are commonly used noninvasive imaging modalities for the evaluation of ischaemic heart disease. Both modalities have proved clinically useful in the entire spectrum of coronary artery disease. Both techniques can detect coronary artery disease and provide prognostic information. Both techniques can identify lowrisk and high-risk subsets among patients with known or suspected coronary artery disease and thus guide patient management decisions. [18] [19] [20] [21] In patients with acute myocardial infarction, both techniques have been used to identify residual viable tissue and predict improvement of function over time. [22] [23] [24] [25] [26] In patients with chronic ischaemic left ventricular (LV) dysfunction, viability assessment with either modality can be used to predict improvement of function after revascularisation and thus guide patient treatment. [27] [28] [29] Hence, the use of noninvasive cardiac imaging can help guide management and potentially reduce healthcare costs. 30 The question remains what is the optimal noninvasive cardiac imaging method in which setting? This article evaluates the value of the two modalities in: (1) the detection of coronary artery disease, (2) the prognosis of coronary artery disease in patients with known or suspected coronary artery disease, (3) prediction of functional recovery following acute myocardial infarction and (4) prediction of functional recovery after revascularisation in patients with chronic ischaemic LV dysfunction. To provide the most objective information, only direct comparative studies on stress echocardiography and perfusion imaging in the same patients are included and pooled analysis of the data was performed.
weighted sensitivities and specificities were calculated. Comparison of sensitivities and specificities was performed using McNemar testing; a P-value <0.05 was considered significant.
Results

Detection of coronary artery disease
Seventeen direct comparisons (1405 patients) with different stressors (five exercise, two adenosine, one dipyridamole, eight dobutamine, and one combined adenosine and dobutamine) were identified ( Table 1) . Pooling of the data showed a slightly higher overall sensitivity for myocardial perfusion imaging as compared to stress echocardiography (84 vs 80%, P<0.05). This finding is in line with the ischaemic cascade ( Fig. 1) , since perfusion abnormalities (detected by perfusion imaging) proceed systolic dysfunction (detected by stress echocardiography). 31 On the other hand, stress echocardiography was more specific compared to perfusion imaging (86 vs 77%, Pϭ0.001). Fig. 2 demonstrates the differences in sensitivity and specificity of the two modalities. It should be noted that the gold standard for the presence/absence of coronary artery disease was angiography in these studies, which may affect specificity of the tests. In the majority of the studies ≥50% stenosis was used as the definition of significant coronary artery disease. In the study of Marwick et al., 9 results were also analysed with a cutoff of >70% stenosis. The results were altered little using this cutoff, as only four patients had a stenosis severity of 50-70%.
Pharmacological stress can be a useful alternative to exercise stress protocols in patients who are unable to exercise because of neurological, orthopedic, or peripheral vascular disease. Because wall motion abnormalities are a consequence of myocardial ischaemia, dobutamine may be more effective than vasodilator (adenosine or dipyridamole) stress echocardiography. 32 In line with this, combined data from seven direct comparative studies demonstrated that dobutamine stress echocardiography had a higher sensitivity for the diagnosis of coronary artery disease than vasodilator stress echocardiography, while specificity was similar. When dobutamine stress echocardiography was compared to dobutamine or vasodilator perfusion scintigraphy, dobutamine echocardiography was equally sensitive but slightly more specific than perfusion scintigraphy. 33 Two subgroups of patients were analysed separately: hypertensive patients and female patients.
In patients with hypertension, abnormal thallium perfusion results have been demonstrated in the absence of obstructive coronary artery disease; 34, 35 this may lower specificity. Summarised data from two studies ( Table 2 , 286 patients) have demonstrated a somewhat higher sensitivity for perfusion imaging compared to stress echocardiography (87 vs 74%, P<0.005), and confirmed the lower specificity for perfusion imaging (44 vs 85%, P<0.001). 36, 37 The diagnosis of coronary artery disease in women may be more challenging due to the lower prevalence of coronary artery disease. In addition, single-vessel disease is a common finding in women. 38, 39 The accuracy of perfusion imaging appears to be decreased in women with breast tissue attenuation, 39 and the smaller LV chamber size in women. 40 Pooled data from three direct comparisons [41] [42] [43] revealed a comparable sensitivity of the two techniques (71 vs 80%, Pϭns) (175 patients, Table 2 ) with a higher specificity of stress echocardiography for the detection of coronary artery disease (72 vs 89%, P<0.01). Comparative studies on adenosine stress imaging in patients with hypertension and women are not available. Further research on the relative value of adenosine stress echocardiography and nuclear perfusion imaging in these subgroups is needed.
Prognosis in coronary artery disease
Noninvasive cardiac imaging is frequently used for risk stratification of patients with known or suspected coronary artery disease. There are two direct comparisons available on the prognostic value of myocardial perfusion imaging and stress echocardiography. Geleijnse et al. 18 studied 220 patients with chest pain with dobutamine-atropine stress echocardiography and simultaneous technetium-99m sestamibi single photon emission computed tomography (SPECT) imaging. During follow-up of 31±15 months, 24 patients had hard cardiac events (nonfatal myocardial infarction or cardiac death). A normal test was related to a good prognosis, with a low annual cardiac event rate of 0.4% by echocardiography and 0.5% by perfusion imaging. In that study, stress echocardiography and technetium-99m sestamibi SPECT provided comparable prognostic information.
Olmos et al. 19 studied 248 patients who underwent exercise echocardiography simultaneously with thallium-201 SPECT. During follow-up (obtained in 225 patients with a mean follow-up of 3.7±2.0 years), 64 cardiac events occurred (eight nonfatal infarctions and seven cardiac deaths). A significant difference was observed between 
Assessment of myocardial viability
The hallmark of viability on dobutamine echocardiography is the improvement of wall motion during the infusion of low-dose dobutamine (5-10 µg kg
). More recent studies have employed a low-high dose protocol (with dosages up to 40 µg kg −1 min −1 , with the addition of atropine). This protocol allows assessment of both viability (response during low-dose dobutamine) and stress-induced ischaemia (response during high-dose dobutamine). For nuclear imaging, different techniques are available. Thallium-201 imaging can be used to evaluate perfusion and cell membrane integrity. Two protocols are used mainly: rest-redistribution imaging and stressredistribution-reinjection imaging. [27] [28] [29] While restredistribution imaging provides only information on myocardial viability, the reinjection protocol allows assessment of stress-induced ischaemia and viability.
Technetium-99m sestamibi can be used to assess perfusion and intact mitochondria. Sestamibi imaging is performed under resting conditions; in the absence of a stress study, this protocol only provides information on viability. It has been demonstrated that the addition of nitrates before tracer administration enhances viability detection. 44 Glucose utilisation can be evaluated with F18-fluorodeoxyglucose (FDG). FDG imaging can nowadays be performed with positron emission tomography and SPECT. The introduction of SPECT imaging has contributed to a more widespread use of FDG. 45 Generally, cardiac FDG uptake is compared with regional perfusion. Viability is defined when perfusion/FDG uptake is normal, or when perfusion is reduced with enhanced FDG uptake.
Prediction of functional recovery after acute myocardial infarction
The phenomenon of reversible dysfunction after myocardial infarction, known as stunning has been well established. 46, 47 The presence of viable, but stunned myocardium has been used to predict functional recovery. Five studies [22] [23] [24] [25] [26] with 209 patients and 958 dyssynergic myocardial segments, compared perfusion imaging with stress echocardiography in the same patient population after acute myocardial infarction and aimed at the prediction of recovery of function ( Table 3 ). All of these studies used dobutamine stress, in most studies a low-dose dobutamine protocol was employed for echocardiography. Nuclear imaging tended to have a higher sensitivity (although not significant), Fig. 1 The ischaemic cascade represents a sequence of pathophysiologic events caused by coronary artery disease. Nuclear imaging probes an earlier event (hypo-perfusion) in the ischaemic cascade than stress echocardiography does (systolic dysfunction).
Fig. 2
Sensitivity and specificity of stress echocardiography and nuclear imaging for the detection of coronary artery disease (data based on Refs. 1-17). ,=echocardiography; j= nuclear.
whereas stress echocardiography was more specific in the prediction of recovery of function (Fig. 3) . Table 4 shows the accuracy of different viability techniques for the prediction of improvement of function after revascularisation. 29 The nuclear imaging techniques appear to have a higher sensitivity for the prediction of functional recovery whereas stress echocardiography appears more specific. Various studies have directly compared some form of nuclear imaging to stress echocardiography. Panza et al. 48 have performed a head-to-head comparison between thallium-201 imaging and dobutamine stress echocardiography in patients with chronic ischaemic LV dysfunction. A total of 311 segments were analysed by both techniques; 84% of these were classified as viable and 16% as nonviable on thallium-201 imaging. The majority of the 'thallium-201 nonviable segments' did not exhibit contractile reserve. However, an additional 36% of the 'thallium-201 viable segments' also did not exhibit contractile reserve. Thus, the results indicated that thallium-201 imaging was more sensitive than dobutamine echocardiography for the detection of viable tissue. Similar results were obtained by Cornel et al. 49 who evaluated 40 patients with chronic ischaemic LV dysfunction with FDG imaging and dobutamine echocardiography. Again, nuclear imaging was more sensitive for the detection of viable tissue as evidenced by the 27% of the dysfunctional segments with FDG uptake but without contractile reserve (Fig. 4) . Various studies have subsequently compared the predictive accuracy of nuclear imaging with dobutamine echocardiography. Currently, a total of 18 studies [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] (with 563 patients) have performed a direct comparison between the two modalities (Table 5 ). Different nuclear techniques were used: three studies used FDG PET, five thallium-201 reinjection and 10 thallium-201 rest-redistribution. Two studies used low-high dose dobutamine echocardiography and the remaining 16 used lowdose dobutamine echocardiography. Pooling of these data yielded a higher sensitivity for nuclear imaging (88 vs 76%, P<0.05) and a higher specificity for dobutamine echocardiography (81 vs 53%, P<0.05). In eight studies (see Table 5 ), some form of stress imaging (either thallium-201 reinjection or low-high dose dobutamine echocardiography) was used; to make the comparison more balanced (and only restricted to viability assessment) the analysis was repeated after exclusion of these eight studies. The discrepancy between nuclear imaging and dobutamine echocardiography for the prediction of functional outcome after revascularisation became even more outspoken (Fig. 5) .
Prediction of functional recovery after revascularisation in chronic ischaemic LV dysfunction
It is conceivable that different levels of ultrastructural cell damage account for this discrepancy: the inotropic response during dobutamine stimulation may be lost while more basal characteristics such as cell membrane integrity and glucose utilisation are still intact. Besides prediction of improvement of function after revascularisation, prediction of long-term survival may be more important. Currently, no direct comparative studies are available on the prognostic value of nuclear imaging and stress echocardiography in patients with ischaemic cardiomyopathy.
Recent developments: simultaneous assessment of function and perfusion
Recently, different technical developments have been implemented in both perfusion imaging and stress echocardiography that further optimised the techniques. Myocardial perfusion imaging has been improved by the introduction of new cameras, imaging protocols, attenuation and scatter correction. 68, 69 For echocardiography, second harmonic imaging has markedly improved endocardial border detection, which could even be further enhanced by intravenous administration of contrast agents that opacify the LV cavity. [70] [71] [72] Colour kinesis and tissue Doppler echocardiography may allow quantification of function, 73, 74 which may enhance reproducibility and diagnostic accuracy.
Other recent developments have aimed at providing integrated information on function and perfusion. Both gated SPECT imaging and contrast echocardiography allow simultaneous assessment of function and perfusion. 75, 76 Over the past 5 years ECG-gated SPECT has become state-of-the-art in cardiac myocardial perfusion imaging. Various comparative studies have demonstrated excellent accuracy of gated SPECT for the assessment of both regional and global LV function. 77 Smanio et al. 78 have demonstrated that combination of perfusion and function (assessed by gating) resulted in significantly higher diagnostic accuracy for detection/ exclusion of coronary artery disease. Moreover, the integrated information of function and perfusion allows superior prognostification in patients with known or suspected coronary artery disease, as demonstrated recently by Sharir et al. 79 Contrast echocardiography also allows simultaneous assessment of function and perfusion. With the introduction of contrast agents that can be administered intravenously, the use of contrast echocardiography has now become feasible outside the catheterisation laboratory. In combination with harmonic and intermittent imaging, quantitative assessment of perfusion has become possible.
Recently, Kaul et al. 80 have shown an excellent concordance between contrast echocardiography and myocardial perfusion imaging. In 30 patients, the agreement for detecting absence/presence of coronary artery disease was 86%. However, two multicentre trials have demonstrated a less favourable agreement between perfusion imaging and contrast echocardiography. 81, 82 Marwick et al. 81 showed that, for the detection of extensive perfusion defects on SPECT perfusion imaging, contrast echocardiography had a sensitivity ranging from 13 to 48% with a specificity ranging from 63 to 100%. Jucquois et al. 82 suggested that the discrepancy between the two techniques could in part be related to attenuation artifacts on SPECT (inferior wall) and suboptimal visualisation of the anterior and lateral walls by echocardiography. However, in experienced settings, adequate quantification of myocardial blood flow and quantification of coronary artery stenoses is possible, as demonstrated by Wei and colleagues. 83, 84 Besides detection of coronary artery disease, evaluation of patients with acute myocardial infarction is feasible with contrast echocardiography and is particularly useful for assessment of 'the no-reflow phenomenon' after thrombolysis or percutaneous interventions. 85, 86 Finally, the feasibility of contrast echocardiography for assessment of viability after acute infarction 87 and in the setting of chronic LV dysfunction 88 has been demonstrated. Thus, in the near future, the combined assessment of perfusion and function by echocardiography and SPECT will allow a more complete assessment of patients with coronary artery disease.
Clinical implications and conclusions
Both myocardial perfusion imaging and stress echocardiography have proved to be extremely useful noninvasive tests for the evaluation of coronary artery disease. Due to basic differences between the two tests, perfusion imaging is a sensitive test with a somewhat lower specificity DSE  32  1090  81  80  77  85  Tl-201 RR  22  557  86  59  69  80  Tl-201 RI  11  301  88  50  57  83  MIBI  20  488  81  66  71  77  FDG PET  20  598  93  58  71  86 DSE=dobutamine stress echocardiography; FDG=F18-fluorodeoxyglucose; MIBI=technetium-99m sestamibi; NPV=negative predictive value; PET=positron emission tomography; PPV=positive predictive value; RR=rest-redistribution; RI=reinjection; Tl-201=thallium-201 chloride.
Fig. 4
Agreement and disagreement between FDG SPECT and low-dose dobutamine echocardiography in dysfunctional myocardium (reprinted with permission from Cornel et al. 49 ).
for the detection of coronary artery disease; the converse is true for stress echocardiography. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] This systematic review focuses on direct comparative studies on stress echocardiography and perfusion imaging in order to provide the most objective information. Nevertheless, a potential risk of pooling data from different studies is to mix patients with different clinical characteristics and risk profile. Two available direct head-to-head comparative studies demonstrated a similar prognostic value of perfusion imaging and stress echocardiography. Larger comparisons are needed to draw further conclusions.
For the assessment of myocardial viability after acute infarction the modalities seem to be equally sensitive, whereas stress echocardiography is the more specific test. [22] [23] [24] [25] [26] Hence, for the early assessment of viability stress echocardiography may be preferable. However, specificity is determined by segments that are nonviable that do not improve in function. A lower specificity suggests that a substantial percentage of segments that are viable do not recover in function. Most studies have evaluated recovery of function at a rather short time-interval after infarction (<3 months) and longer follow-up may be needed.
In patients with chronic ischaemic ventricular dysfunction, nuclear imaging has a high sensitivity for the detection of viable myocardium and a low specificity, whereas the converse is true for stress echocardiography. [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] The lower specificity of nuclear imaging can again be an issue of duration of follow-up. Recent data have demonstrated that a substantial percentage of segments need longer time after revascularisation to (fully) recover in function. 89 In addition, large direct comparative studies are required to evaluate the prognostic value of nuclear imaging and stress echocardiography in patients with chronic ischaemic left ventricular dysfunction. In conclusion, the current analysis demonstrated that both techniques are useful in the evaluation of patients with coronary artery disease, although small differences between accuracies exist in different settings. The most important factor for using a test remains the local expertise and availability of these imaging modalities. In addition, patient characteristics (habitus, acoustic window, pregnancy) may influence the choice of the technique, and finally the studies discussed generally reflect the experience in university centers and many of these studies may be influenced by selection and referral bias, which limits application of the results to the general population.
